Ameriprise’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-29,388
| Closed | -$4.44M | – | 4125 |
|
|
2022
Q3 | $4.44M | Sell |
29,388
-20,501
| -41% | -$3.1M | ﹤0.01% | 2305 |
|
|
2022
Q2 | $7.27M | Buy |
49,889
+5,844
| +13% | +$851K | ﹤0.01% | 2006 |
|
|
2022
Q1 | $5.22M | Sell |
44,045
-226
| -0.5% | -$26.8K | ﹤0.01% | 2394 |
|
|
2021
Q4 | $6.1M | Sell |
44,271
-4,738
| -10% | -$653K | ﹤0.01% | 2329 |
|
|
2021
Q3 | $6.81M | Sell |
49,009
-4,257
| -8% | -$591K | ﹤0.01% | 2168 |
|
|
2021
Q2 | $5.17M | Buy |
53,266
+2,095
| +4% | +$203K | ﹤0.01% | 2432 |
|
|
2021
Q1 | $3.5M | Sell |
51,171
-6,572
| -11% | -$449K | ﹤0.01% | 2606 |
|
|
2020
Q4 | $4.95M | Sell |
57,743
-13,376
| -19% | -$1.15M | ﹤0.01% | 2283 |
|
|
2020
Q3 | $4.62M | Sell |
71,119
-13,656
| -16% | -$888K | ﹤0.01% | 2137 |
|
|
2020
Q2 | $6.2M | Sell |
84,775
-5,484
| -6% | -$401K | ﹤0.01% | 1906 |
|
|
2020
Q1 | $3.07M | Buy |
90,259
+20,817
| +30% | +$708K | ﹤0.01% | 2235 |
|
|
2019
Q4 | $3.78M | Buy |
69,442
+5,030
| +8% | +$274K | ﹤0.01% | 2397 |
|
|
2019
Q3 | $2.69M | Sell |
64,412
-3,431
| -5% | -$143K | ﹤0.01% | 2548 |
|
|
2019
Q2 | $2.97M | Sell |
67,843
-10,328
| -13% | -$452K | ﹤0.01% | 2532 |
|
|
2019
Q1 | $4.02M | Buy |
78,171
+29,072
| +59% | +$1.5M | ﹤0.01% | 2361 |
|
|
2018
Q4 | $1.82M | Buy |
49,099
+13,552
| +38% | +$501K | ﹤0.01% | 2688 |
|
|
2018
Q3 | $1.34M | Buy |
+35,547
| New | +$1.34M | ﹤0.01% | 2961 |
|